{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:22:20Z","timestamp":1793935340594,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jacep.2024.08.005","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T14:09:01Z","timestamp":1727878141000},"page":"2701-2710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Direct Oral Anticoagulants for Rheumatic\u00a0Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-1692","authenticated-orcid":false,"given":"Ayman R.","family":"Fath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"Aglan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamah","family":"Altaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendre","family":"Fichardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Almomani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hammadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Vinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemal","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Jneid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9853-7591","authenticated-orcid":false,"given":"Islam Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2024.08.005_bib1","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jacep.2024.08.005_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.08.005_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.21037\/cdt.2019.10.07","article-title":"Rheumatic heart disease: current status of diagnosis and therapy","volume":"10","author":"Peters","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.jacep.2024.08.005_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2024.08.005_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/cvr\/cvaa344","article-title":"Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease","volume":"118","author":"Benz","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2024.08.005_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/heartjnl-2019-314898","article-title":"Stroke and thromboembolism prevention in atrial fibrillation","volume":"106","author":"Jame","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2024.08.005_bib7","doi-asserted-by":"crossref","first-page":"B41","DOI":"10.1093\/eurheartjsupp\/suad065","article-title":"DOACs and rheumatic valvulopathy: always a red light?","volume":"25","author":"Rochira","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jacep.2024.08.005_bib8","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa2209051","article-title":"Rivaroxaban in rheumatic heart disease-associated atrial fibrillation","volume":"387","author":"Connolly","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2024.08.005_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jacc.2023.10.031","article-title":"Comparison of direct oral anticoagulants vs vitamin k antagonists after transcatheter mitral valve replacement","volume":"83","author":"B\u00e8ze","year":"2024","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.08.005_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jacep.2024.08.005_bib11","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/j.hlc.2019.08.020","article-title":"A\u00a0validation study: how predictive is a diagnostic coding algorithm at identifying rheumatic heart disease in Western Australian hospital data?","volume":"29","author":"Fitz-Gerald","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacep.2024.08.005_bib12","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"22","key":"10.1016\/j.jacep.2024.08.005_bib13","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.08.005_bib14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2024.08.005_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.08.005_bib16","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2024.08.005_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2024.08.005_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2024.08.005_bib19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2024.08.005_bib20","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve","volume":"383","author":"Guimaraes","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2024.08.005_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.amjcard.2023.07.141","article-title":"An evidence-based approach to anticoagulation therapy comparing direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: a systematic review, meta-analysis, and network meta-analysis","volume":"206","author":"Suppah","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.08.005_bib22","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.jtcvs.2021.07.034","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: a meta-analysis","volume":"165","author":"Yokoyama","year":"2023","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacep.2024.08.005_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jtcvs.2020.07.117","article-title":"Mitral valve repair versus replacement in patients with rheumatic heart disease","volume":"164","author":"Chen","year":"2022","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacep.2024.08.005_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jtcvs.2020.01.053","article-title":"Outcomes of mitral valve repair compared with replacement for patients with rheumatic heart disease","volume":"162","author":"Fu","year":"2021","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacep.2024.08.005_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/heartasia-2017-010916","article-title":"Outcomes after mitral valve surgery for rheumatic heart disease","volume":"9","author":"Russell","year":"2017","journal-title":"Heart Asia"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24007461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24007461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T03:18:07Z","timestamp":1764559087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X24007461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2405500X24007461"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2024.08.005","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct Oral Anticoagulants for Rheumatic\u00a0Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2024.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}